Company | CMP | Change | Change (%) | Mkt Cap | PE |
|---|---|---|---|---|---|
S Chand & Company Ltd | 204.98 | -2.10 | -1.01 | 722.55 | 33.33 |
Flair Writing Industries Ltd | 316.2 | -3.75 | -1.17 | 3332.60 | 29.7 |
Doms Industries Ltd | 2300.5 | -34.90 | -1.49 | 13961.18 | 74.58 |
Chetana Education Ltd | 80.5 | 2.60 | 3.34 | 164.22 | 11.82 |
Infomedia Press Ltd | 6.61 | 0.00 | 0.00 | 33.18 | 0 |
Kokuyo Camlin Ltd | 115.53 | 4.29 | 3.86 | 1158.81 | 192.5 |
Navneet Education Ltd | 140.58 | -8.95 | -5.99 | 3180.10 | 13.57 |
Sundaram Multi Pap Ltd | 2.03 | 0.05 | 2.53 | 96.20 | 0 |
Linc Ltd | 126.5 | -2.47 | -1.92 | 752.54 | 20.41 |
Todays Writing Instruments Ltd | 0.3 | 0.00 | 0.00 | 0.38 | 0 |
Repro India Ltd | 511.3 | -3.50 | -0.68 | 732.36 | 0 |
The company said its revenue growth was supported by an 8% increase in underlying volumes.
8 Aug 2025|11:55 AM
Biosimilars revenue grew 18% YoY to ₹2,458 crore in the quarter. This growth was driven by sustained global demand
8 Aug 2025|11:34 AM
The company’s operating performance saw a notable improvement. EBITDA jumped 30.2% to ₹56 crore. This is compared to ₹43 crore in Q1FY25.
8 Aug 2025|11:13 AM
On the operational front, EBITDA rose 38.6% YoY to ₹525 crore. This is against ₹379 crore a year ago.
8 Aug 2025|10:51 AM
Revenue for the quarter rose modestly to ₹6,560 crore, a 3.6% increase over ₹6,334 crore reported a year earlier.
8 Aug 2025|10:36 AM
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
